IPH6501
innate
[]
innate #pharma, a leading biopharmaceutical company, showcases its groundbreaking proprietary #technology, iph6501, a tetra-specific anket-r nk cell engager, at the eha 2023 congress. discover the #future of cancer #immunotherapy 
By discovering the latest data on pharmaceutical #Clinical #Patent #News #indication #Pipeline to empower IP and R&D teams make more strategic decisions.